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STATE-OF-THE-ART PAPER STATE-OF-THE-ART PAPERAnatomy Versus Physiology in Coronary Artery Disease 1639K. Lance Gould, Nils P. Johnson, Timothy M. Bateman, Rob S. Beanlands, Frank M. Bengel,
Robert Bober, Paolo G. Camici, Manuel D. Cerqueira, Benjamin J. W. Chow, Marcelo F. Di Carli,
Sharmila Dorbala, Henry Gewirtz, Robert J. Gropler, Philipp A. Kaufmann, Paul Knaapen,
Juhani Knuuti, Michael E. Merhige, K. Peter Rentrop, Terrence D. Ruddy, Heinrich R. Schelbert,
Thomas H. Schindler, Markus Schwaiger, Stefano Sdringola, John Vitarello, Kim A. Williams, Sr,
Donald Gordon, Vasken Dilsizian, Jagat Narula
Angiographic severity of coronary artery stenosis has historically been the primary guide to
revascularization or medical management of coronary artery disease. Gould and colleagues
review basic clinical concepts of coronary physiologydpressure and ﬂowdas clinical tools for
treating patients. Positron emission tomography (PET) perfusion imaging has the ability to
provide all of the essential noninvasive measures of physiologic severity that, when integrated
with clinical judgment, may be useful for identifying patients for whom revascularization
procedures may reduce coronary events. The authors conclude that the currently available
evidence base validates PET perfusion imaging as a powerful clinical tool to guide
revascularization decisions.CLINICAL RESEARCH INTERVENTIONAL CARDIOLOGYPredictors and Outcomes of Side Branch Occlusion 1654
Joo-Yong Hahn, Woo Jung Chun, Ji-Hwan Kim, Young Bin Song, Ju Hyeon Oh, Bon-Kwon Koo,
Seung Woon Rha, Cheol Woong Yu, Jong-Sun Park, Jin-Ok Jeong, Seung-Hyuk Choi, Jin-Ho Choi,
Myung-Ho Jeong, Jung Han Yoon, Yangsoo Jang, Seung-Jea Tahk, Hyo-Soo Kim, Hyeon-Cheol Gwon
The COBIS (COronary Bifurcation Stent) II registry was designed to investigate the
predictors and outcomes of side branch (SB) occlusion after main vessel (MV) stenting in
coronary bifurcation lesions. Consecutive patients undergoing percutaneous coronary
intervention using drug-eluting stents for bifurcation lesions with SB 2.3 mm were
prospectively enrolled. SB occlusion occurred in 8.4% of 2,227 bifurcation lesions.
Independent predictors of SB occlusion were pre-procedural percent diameter stenosis of the
SB 50% and the proximal MV 50%, SB lesion length, and acute coronary syndrome.
Of 187 occluded SBs, ﬂow was restored spontaneously in 14% and restored by SB
intervention in 55%, but was not restored in 31%. Jailed wire in the SB was associated
with ﬂow recovery (75% vs. 58%). During follow-up, cardiac death or myocardial
infarction occurred more frequently in patients with SB occlusion than in those without
SB occlusion.(continued on page A-22)
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Melenovsky and colleagues hypothesized that right ventricular (RV) dysfunction is linked to
weight loss, abnormal body composition, and worsened prognosis in patients with advanced
heart failure (HF). Subjects with advanced HF (n ¼ 408) underwent prospective assessment
of body composition (skinfold thickness and dual-energy X-ray absorptiometry),
comprehensive echocardiography, and blood testing. Subjects with RV dysfunction (51%)
had lower body mass index, had lower fat mass index, and were more likely to display
cachexia, deﬁned as >5% loss of body weight over 6 months. During a median follow-up of
541 days, the risk of clinical deterioration was greater in subjects with RV dysfunction and
cachexia. These results show a correlation between RV dysfunction, cardiac cachexia, and
poor prognosis, suggesting a mechanistic interplay.
Editorial Comment: Mandeep R. Mehra, p. 1671HEART RHYTHM DISORDERSSurvival After ICD Shock According to Rhythm Shocked 1674
Brian D. Powell, Leslie A. Saxon, John P. Boehmer, John D. Day, F. Roosevelt Gilliam III,
Paul A. Heidenreich, Paul W. Jones, Matthew J. Rousseau, David L. Hayes
Powell and colleagues sought to determine if the mortality risk associated with inappropriate
implantable cardioverter-deﬁbrillator (ICD) shocks is due to the underlying arrhythmia or
the shock itself. First shock episode rhythms from 3,809 patients were adjudicated, and
mortality was compared to a control group without a shock. Compared with no shock, there
was increased mortality in those who received their ﬁrst shock for monomorphic ventricular
tachycardia (hazard ratio [HR]: 1.65), ventricular ﬁbrillation/polymorphic ventricular
tachycardia (HR: 2.10), and atrial ﬁbrillation/ﬂutter (HR: 1.61). However, there was no
increased risk following ﬁrst shocks due to sinus tachycardia and supraventricular tachycardia
or noise/artifact/oversensing. These results suggest that the adverse prognosis following ﬁrst
ICD shock appears to be more related to the underlying arrhythmia than to an adverse effect
from the shock itself.
Editorial Comment: Eric S. Williams, Jeanne E. Poole, p. 1680(continued on page A-23)
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Barbara P. Rogge, Dana Cramariuc, Mai Tone Lønnebakken, Christa Gohlke-Bärwolf,
John B. Chambers, Kurt Boman, Eva Gerdts
Rogge and colleagues investigated whether being overweight or obese impacted outcomes in
patients with asymptomatic aortic valve stenosis (AS). Cardiovascular events in 1,664 patients
with AS were recorded during a mean of 4.3 years follow-up. The AS progression rate did
not differ between baseline body mass index classes. In multivariate analyses, overweight and
obese subjects had higher rates of total mortality and higher rates of combined hospitalization
for heart failure and death from any cause. There was no signiﬁcant difference in the rates of
ischemic cardiovascular- and AS-related events in overweight subjects compared with
normal-weight patients. Being overweight or obese does not appear to alter AS progression
rates, either clinically or by echocardiography, but it may be linked to increased mortality.
Editorial Comment: Jean G. Dumesnil, Philippe Pibarot, p. 1691BIOMARKERSMental Stress and Cardiac Troponin T Release 1694
Antonio I. Lazzarino, Mark Hamer, David Gaze, Paul Collinson, Andrew Steptoe
Mental stress is a recognized risk factor for cardiovascular disease (CVD), although the
mechanisms remain unclear. Lazzarino and colleagues studied the effect of mental stress on
salivary cortisol release and plasma concentrations of cardiac troponin T (cTnT) using a
high-sensitivity assay in healthy older individuals without a history of CVD. There was a
robust association between cortisol response and detectable high-sensitivity cTnT (odds ratio:
3.98). The association remained after the analysis was restricted to participants without
coronary calciﬁcation and after adjustment for coronary calciﬁcation in participants with
positive Agatston scores. These results linking cortisol response to mental stress with
circulating cTnT levels in individuals without coronary artery disease suggests a complex
interplay that is not simply mediated by provocable ischemia due to ﬁxed coronary stenoses.
Editorial Comment: Kai M. Eggers, p. 1702(continued on page A-24)
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Jacob A. Udell, Hong Lu, Donald A. Redelmeier
Udell and colleagues studied whether fertility therapy might contribute to subsequent
cardiovascular risk by performing a population-based cohort analysis of women who gave
birth in Ontario, Canada, from 1993 to 2010. Subjects who did or did not receive fertility
therapy in the 2 years prior to delivery were segregated. After 9.7 years of median follow-up,
the 0.6% of women who delivered following fertility therapy had fewer cardiovascular events
than controls (103 events vs. 117 events per 100,000 person-years), with an adjusted hazard
ratio of 0.55. Women who received fertility therapy also had lower risk-adjusted all-cause
mortality, thromboembolic events, and subsequent depression, alcoholism, and self-harm.
These results should allay any concern that successful fertility therapy increases the risk of
cardiovascular disease later in life.
Editorial Comment: Jolien W. Roos-Hesselink, Mark R. Johnson, p. 1713PREGNANCY AND HEART DISEASEPre-Eclampsia and the Risk of Peripartum Cardiomyopathy 1715
Natalie Bello, Iliana S. Hurtado Rendon, Zoltan Arany
Bello and colleagues systematically reviewed the peripartum cardiomyopathy (PPCM)
literature to determine the prevalence of pre-eclampsia (PE) as a pre-disposing risk factor.
The prevalence of other risk factors, such as hypertensive disorders, multiple gestations,
and multiparity, were also assessed. Data from 22 studies (n ¼ 979) were included in this
analysis. The pooled prevalence of PE was 22%, which was more than quadruple the
5% average worldwide background rate of PE in pregnancy. There were no geographic
or racial differences detected in the prevalence of PE in women with PPCM. The rates
of hypertension during pregnancy and multiple gestations were also elevated. These ﬁndings
support the concept of a shared pathogenesis between PE and PPCM.
